The Europe Intrapartum Monitoring Devices Market should witness market growth of 6.3% CAGR during the forecast period (2022-2028).
The electrodes for intrapartum monitoring are either minimally invasive or externally placed. In contrast to the internal monitoring intrapartum electrodes, which include intrauterine pressure catheters and fetal scalp electrodes, the exterior fetal monitoring electrodes comprise transducers for FHR and transducers for uterine contractions. Due to its greater adoption rates and the growing demand for internal monitoring in mothers with gestational diabetes mellitus (GDM) as well asobesity, the use of fetal scalp electrodes has increased.
When external monitors cannot produce the appropriate findings, fetal scalpelectrodes (FSE) are used to monitor the fetus in urgent situations. On the area of the fetal body nearest to the birth canal, the FSE is positioned just below the skin.Fetal heart rate monitoring is one of the main components of external fetal monitoring. Doppler ultrasounds are typically used to monitor external FHR. The transducer is positioned on the mother for precise signaling and improved outcomes after palpating and finding the fetus. Auscultation is a recurring procedure that occurs throughout labor and needs the patient to remain still, making delivery challenging. Nonetheless, external monitoring utilizing transducers during low-risk births is considered secure and dependable.
The rising life expectancy and burgeoning female population in Europe are anticipated to open new market expansion opportunities. In addition, maternal and newborn mortality rates in the region have successfully decreased due to the European Health Commission's emphasis on enhancing maternal care across the region. Hence, more governments are focusing on strengthening the care facilities for mothers and children. About 15% of births in the region experience issues during pregnancy and delivery. Preterm birth and fetal hypoxia are the main issues. Despite the widespread use of monitoring, over 30.000 newborns in Europe are predicted to have birth asphyxia each year. As a result, the demand for intrapartum monitoring devices is increasing in the region, boosting the expansion of the market.
The Germany market dominated the Europe Intrapartum Monitoring Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $81.4 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.3% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022-2028).
Based on Product Type, the market is segmented into Monitors and Electrodes. Based on Method, the market is segmented into Non-invasive and Invasive. Based on End-user, the market is segmented into Hospitals, Maternity Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., MindChild Medical, Inc., Arjo AB (Huntleigh Healthcare ltd.), Stalwart Meditech Private Limited, MedGyn Products, Inc., Cardinal Health, Inc., GE HealthCare Technologies, Inc., CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Olympus Corporation.
The electrodes for intrapartum monitoring are either minimally invasive or externally placed. In contrast to the internal monitoring intrapartum electrodes, which include intrauterine pressure catheters and fetal scalp electrodes, the exterior fetal monitoring electrodes comprise transducers for FHR and transducers for uterine contractions. Due to its greater adoption rates and the growing demand for internal monitoring in mothers with gestational diabetes mellitus (GDM) as well asobesity, the use of fetal scalp electrodes has increased.
When external monitors cannot produce the appropriate findings, fetal scalpelectrodes (FSE) are used to monitor the fetus in urgent situations. On the area of the fetal body nearest to the birth canal, the FSE is positioned just below the skin.Fetal heart rate monitoring is one of the main components of external fetal monitoring. Doppler ultrasounds are typically used to monitor external FHR. The transducer is positioned on the mother for precise signaling and improved outcomes after palpating and finding the fetus. Auscultation is a recurring procedure that occurs throughout labor and needs the patient to remain still, making delivery challenging. Nonetheless, external monitoring utilizing transducers during low-risk births is considered secure and dependable.
The rising life expectancy and burgeoning female population in Europe are anticipated to open new market expansion opportunities. In addition, maternal and newborn mortality rates in the region have successfully decreased due to the European Health Commission's emphasis on enhancing maternal care across the region. Hence, more governments are focusing on strengthening the care facilities for mothers and children. About 15% of births in the region experience issues during pregnancy and delivery. Preterm birth and fetal hypoxia are the main issues. Despite the widespread use of monitoring, over 30.000 newborns in Europe are predicted to have birth asphyxia each year. As a result, the demand for intrapartum monitoring devices is increasing in the region, boosting the expansion of the market.
The Germany market dominated the Europe Intrapartum Monitoring Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $81.4 Million by 2028. The UK market is anticipated to grow at a CAGR of 5.3% during (2022-2028). Additionally, The France market would exhibit a CAGR of 7.2% during (2022-2028).
Based on Product Type, the market is segmented into Monitors and Electrodes. Based on Method, the market is segmented into Non-invasive and Invasive. Based on End-user, the market is segmented into Hospitals, Maternity Centers and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Koninklijke Philips N.V., MindChild Medical, Inc., Arjo AB (Huntleigh Healthcare ltd.), Stalwart Meditech Private Limited, MedGyn Products, Inc., Cardinal Health, Inc., GE HealthCare Technologies, Inc., CooperVision, Inc. (THE COOPER COMPANIES, INC.), and Olympus Corporation.
Scope of the Study
By Product Type
- Monitors
- Electrodes
By Method
- Non-invasive
- Invasive
By End-user
- Hospitals
- Maternity Centers
- Others
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Koninklijke Philips N.V.
- MindChild Medical, Inc.
- Arjo AB (Huntleigh Healthcare ltd.)
- Stalwart Meditech Private Limited
- MedGyn Products, Inc.
- Cardinal Health, Inc.
- GE HealthCare Technologies, Inc.
- CooperVision, Inc. (THE COOPER COMPANIES, INC.)
- Olympus Corporation
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Intrapartum Monitoring Devices Market, by Product Type
1.4.2 Europe Intrapartum Monitoring Devices Market, by Method
1.4.3 Europe Intrapartum Monitoring Devices Market, by End User
1.4.4 Europe Intrapartum Monitoring Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Intrapartum Monitoring Devices Market by Product Type
3.1 Europe Monitors Market by Country
3.2 Europe Electrodes Market by Country
Chapter 4. Europe Intrapartum Monitoring Devices Market by Method
4.1 Europe Non-invasive Market by Country
4.2 Europe Invasive Market by Country
Chapter 5. Europe Intrapartum Monitoring Devices Market by End User
5.1 Europe Hospitals Market by Country
5.2 Europe Maternity Centers Market by Country
5.3 Europe Others Market by Country
Chapter 6. Europe Intrapartum Monitoring Devices Market by Country
6.1 Germany Intrapartum Monitoring Devices Market
6.1.1 Germany Intrapartum Monitoring Devices Market by Product Type
6.1.2 Germany Intrapartum Monitoring Devices Market by Method
6.1.3 Germany Intrapartum Monitoring Devices Market by End User
6.2 UK Intrapartum Monitoring Devices Market
6.2.1 UK Intrapartum Monitoring Devices Market by Product Type
6.2.2 UK Intrapartum Monitoring Devices Market by Method
6.2.3 UK Intrapartum Monitoring Devices Market by End User
6.3 France Intrapartum Monitoring Devices Market
6.3.1 France Intrapartum Monitoring Devices Market by Product Type
6.3.2 France Intrapartum Monitoring Devices Market by Method
6.3.3 France Intrapartum Monitoring Devices Market by End User
6.4 Russia Intrapartum Monitoring Devices Market
6.4.1 Russia Intrapartum Monitoring Devices Market by Product Type
6.4.2 Russia Intrapartum Monitoring Devices Market by Method
6.4.3 Russia Intrapartum Monitoring Devices Market by End User
6.5 Spain Intrapartum Monitoring Devices Market
6.5.1 Spain Intrapartum Monitoring Devices Market by Product Type
6.5.2 Spain Intrapartum Monitoring Devices Market by Method
6.5.3 Spain Intrapartum Monitoring Devices Market by End User
6.6 Italy Intrapartum Monitoring Devices Market
6.6.1 Italy Intrapartum Monitoring Devices Market by Product Type
6.6.2 Italy Intrapartum Monitoring Devices Market by Method
6.6.3 Italy Intrapartum Monitoring Devices Market by End User
6.7 Rest of Europe Intrapartum Monitoring Devices Market
6.7.1 Rest of Europe Intrapartum Monitoring Devices Market by Product Type
6.7.2 Rest of Europe Intrapartum Monitoring Devices Market by Method
6.7.3 Rest of Europe Intrapartum Monitoring Devices Market by End User
Chapter 7. Company Profiles
7.1 Koninklijke Philips N.V.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.2 MindChild Medical, Inc.
7.2.1 Company Overview
7.2.2 Recent strategies and developments:
7.2.2.1 Partnerships, Collaborations, and Agreements:
7.3 Arjo AB (Huntleigh Healthcare ltd.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental Analysis
7.3.4 Research & Development Expenses
7.4 Stalwart Meditech Private Limited
7.4.1 Company Overview
7.5 MedGyn Products, Inc.
7.5.1 Company Overview
7.6 Cardinal Health, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 GE HealthCare Technologies, Inc.
7.7.1 Company Overview
7.8 CooperVision, Inc. (THE COOPER COMPANIES, INC.)
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.9 Olympus Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
Companies Mentioned
- Koninklijke Philips N.V.
- MindChild Medical, Inc.
- Arjo AB (Huntleigh Healthcare ltd.)
- Stalwart Meditech Private Limited
- MedGyn Products, Inc.
- Cardinal Health, Inc.
- GE HealthCare Technologies, Inc.
- CooperVision, Inc. (THE COOPER COMPANIES, INC.)
- Olympus Corporation
Methodology
LOADING...
